-
1
-
-
0023808730
-
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
-
Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61
-
(1988)
N Engl J Med
, vol.319
, pp. 157-161
-
-
Leclercq, R.1
Derlot, E.2
Duval, J.3
Courvalin, P.4
-
2
-
-
0024437826
-
High-level vancomycin-resistant enterococci causing hospital infections
-
Uttley AH, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-81 (Pubitemid 19223468)
-
(1989)
Epidemiology and Infection
, vol.103
, Issue.1
, pp. 173-181
-
-
Uttley, A.H.C.1
George, R.C.2
Naidoo, J.3
Woodford, N.4
Johnson, A.P.5
Collins, C.H.6
Morrison, D.7
Gilfillan, A.J.8
Fitch, L.E.9
Heptonstall, J.10
-
3
-
-
0036735035
-
First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey
-
Colak D, Naas T, Gunseren F, et al. First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. J Antimicrob Chemother 2002;50:397-401
-
(2002)
J Antimicrob Chemother
, vol.50
, pp. 397-401
-
-
Colak, D.1
Naas, T.2
Gunseren, F.3
-
4
-
-
0033252628
-
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones
-
Hsueh PR, Teng LJ, Pan HJ, et al. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999;20:828-33
-
(1999)
Infect Control Hosp Epidemiol
, vol.20
, pp. 828-833
-
-
Hsueh, P.R.1
Teng, L.J.2
Pan, H.J.3
-
5
-
-
58849090457
-
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006
-
Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009;30:184-6
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 184-186
-
-
Ramsey, A.M.1
Zilberberg, M.D.2
-
6
-
-
0035666687
-
System Report Data summary from January 1992-June 2001, issued August 2001
-
National Nosocomial Infections Surveillance (NNIS)
-
National Nosocomial Infections Surveillance (NNIS) System Report, Data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404-21
-
(2001)
Am J Infect Control
, vol.29
, pp. 404-421
-
-
-
7
-
-
0034787718
-
Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study
-
DOI 10.1128/JCM.39.10.3727-3732.2001
-
Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727-32 (Pubitemid 32954532)
-
(2001)
Journal of Clinical Microbiology
, vol.39
, Issue.10
, pp. 3727-3732
-
-
Fluit, A.C.1
Wielders, C.L.C.2
Verhoef, J.3
Schmitz, F.-J.4
-
8
-
-
0027979631
-
Methicillin-resistant staphylococcus aureus in Europe
-
Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-5 (Pubitemid 24060893)
-
(1994)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.13
, Issue.1
, pp. 50-55
-
-
Voss, A.1
Milatovic, D.2
Wallrauch-Schwarz, C.3
Rosdahl, V.T.4
Braveny, I.5
-
9
-
-
18044365653
-
Community-acquired meticillin-resistant Staphylococcus aureus: An emerging threat
-
DOI 10.1016/S1473-3099(05)70112-2
-
Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-86 (Pubitemid 40602247)
-
(2005)
Lancet Infectious Diseases
, vol.5
, Issue.5
, pp. 275-286
-
-
Zetola, N.1
Francis, J.S.2
Nuermberger, E.L.3
Bishai, W.R.4
-
10
-
-
20144386837
-
Methicillin-resistant Staphylococcus aureus disease in three communities
-
Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44
-
(2005)
N Engl J Med
, vol.352
, pp. 1436-1444
-
-
Fridkin, S.K.1
Hageman, J.C.2
Morrison, M.3
-
11
-
-
0037417230
-
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
-
DOI 10.1056/NEJMoa025025
-
Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-7 (Pubitemid 36384101)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.14
, pp. 1342-1347
-
-
Chang, S.1
Sievert, D.M.2
Hageman, J.C.3
Boulton, M.L.4
Tenover, F.C.5
Downes, F.P.6
Shah, S.7
Rudrik, J.T.8
Pupp, G.R.9
Brown, W.J.10
Cardo, D.11
Fridkin, S.K.12
-
12
-
-
0030841073
-
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [1]
-
DOI 10.1093/jac/40.1.135
-
Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6 (Pubitemid 27341646)
-
(1997)
Journal of Antimicrobial Chemotherapy
, vol.40
, Issue.1
, pp. 135-136
-
-
Hiramatsu, K.1
Hanaki, H.2
Ino, T.3
Yabuta, K.4
Oguri, T.5
Tenover, F.C.6
-
13
-
-
77953265046
-
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit
-
Sanchez Garcia M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010;303:2260-4
-
(2010)
JAMA
, vol.303
, pp. 2260-4
-
-
Sanchez Garcia, M.1
De La Torre, M.A.2
Morales, G.3
-
14
-
-
67649531477
-
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia
-
Jacobson LM, Milstone AM, Zenilman J, et al. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr Infect Dis J 2009;28:445-7
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 445-447
-
-
Jacobson, L.M.1
Milstone, A.M.2
Zenilman, J.3
-
15
-
-
15744365907
-
Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
-
DOI 10.1086/428616
-
Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2005;40:1058-60 (Pubitemid 40418318)
-
(2005)
Clinical Infectious Diseases
, vol.40
, Issue.7
, pp. 1058-1060
-
-
Mangili, A.1
Bica, I.2
Snydman, D.R.3
Hamer, D.H.4
-
16
-
-
79956086972
-
Emergence of daptomycin resistance following vancomycin-unresponsive staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature
-
van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature. Eur J Clin Microbiol Infect Dis 2011;30:603-10
-
(2011)
Eur J Clin Microbiol Infect Dis
, vol.30
, pp. 603-610
-
-
Van Hal, S.J.1
Paterson, D.L.2
Gosbell, I.B.3
-
18
-
-
0034537258
-
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections
-
PII S0924857900003034
-
Moise PA, Schentag JJ. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents 2000;16(Suppl 1):S31-4 (Pubitemid 32007934)
-
(2000)
International Journal of Antimicrobial Agents
, vol.16
, Issue.SUPPL. 1
-
-
Moise, P.A.1
Schentag, J.J.2
-
19
-
-
2942558870
-
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
-
DOI 10.1128/JCM.42.6.2398-2402.2004
-
Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402 (Pubitemid 38747480)
-
(2004)
Journal of Clinical Microbiology
, vol.42
, Issue.6
, pp. 2398-2402
-
-
Sakoulas, G.1
Moise-Broder, P.A.2
Schentag, J.3
Forrest, A.4
Moellering Jr., R.C.5
Eliopoulos, G.M.6
-
20
-
-
43249095689
-
Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus
-
DOI 10.1016/S0924-8579(08)70002-5, PII S0924857908700025
-
Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008;31(Suppl(2):1-9 (Pubitemid 351657677)
-
(2008)
International Journal of Antimicrobial Agents
, vol.31
, Issue.SUPPL. 2
, pp. 1-9
-
-
Gould, I.M.1
-
21
-
-
0025279742
-
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
-
Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227-31 (Pubitemid 20177385)
-
(1990)
Antimicrobial Agents and Chemotherapy
, vol.34
, Issue.6
, pp. 1227-1231
-
-
Small, P.M.1
Chambers, H.F.2
-
22
-
-
2342644251
-
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin
-
DOI 10.1086/383027
-
Woods CW, Cheng AC, Fowler VG Jr, et al. Endocarditis caused by staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 2004;38:1188-91 (Pubitemid 38951269)
-
(2004)
Clinical Infectious Diseases
, vol.38
, Issue.8
, pp. 1188-1191
-
-
Woods, C.W.1
Cheng, A.C.2
Fowler Jr., V.G.3
Moorefield, M.4
Frederick, J.5
Sakoulas, G.6
Meka, V.G.7
Tenover, F.C.8
Zwadyk, P.9
Wilson, K.K.10
-
24
-
-
0037458217
-
Linezolid: The first oxazolidinone antimicrobial
-
Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42
-
(2003)
Ann Intern Med
, vol.138
, pp. 135-142
-
-
Moellering, R.C.1
-
25
-
-
0037821645
-
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
-
DOI 10.1074/jbc.M302109200
-
Colca JR, McDonald WG, Waldon DJ, et al. Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics. J Biol Chem 2003;278:21972-9 (Pubitemid 36792605)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.24
, pp. 21972-21979
-
-
Colca, J.R.1
McDonald, W.G.2
Waldon, D.J.3
Thomasco, L.M.4
Gadwood, R.C.5
Lund, E.T.6
Cavey, G.S.7
Mathews, W.R.8
Adams, L.D.9
Cecil, E.T.10
Pearson, J.D.11
Bock, J.H.12
Mott, J.E.13
Shinabarger, D.L.14
Xiong, L.15
Mankin, A.S.16
-
26
-
-
77951217660
-
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain
-
Betriu C, Morales G, Rodriguez-Avial I, et al. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Antimicrob Agents Chemother 2010;54:2212-15
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2212-2215
-
-
Betriu, C.1
Morales, G.2
Rodriguez-Avial, I.3
-
27
-
-
77951234516
-
Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges
-
Brown SD, Traczewski MM. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Antimicrob Agents Chemother 2010;54:2063-9
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2063-9
-
-
Brown, S.D.1
Traczewski, M.M.2
-
28
-
-
67749127546
-
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent
-
Schaadt R, Sweeney D, Shinabarger D, Zurenko G. In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent. Antimicrob Agents Chemother 2009;53:3236-9
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3236-9
-
-
Schaadt, R.1
Sweeney, D.2
Shinabarger, D.3
Zurenko, G.4
-
29
-
-
78649681818
-
Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea
-
Yum JH, Choi SH, Yong D, et al. Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. Antimicrob Agents Chemother 2010;54:5381-6
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 5381-6
-
-
Yum, J.H.1
Choi, S.H.2
Yong, D.3
-
30
-
-
62549099077
-
Activity of oxazolidinone TR-700 against linezolid-susceptible and-resistant staphylococci and enterococci
-
Livermore DM, Mushtaq S, Warner M, Woodford N. Activity of oxazolidinone TR-700 against linezolid-susceptible and-resistant staphylococci and enterococci. J Antimicrob Chemother 2009;63:713-15
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 713-715
-
-
Livermore, D.M.1
Mushtaq, S.2
Warner, M.3
Woodford, N.4
-
31
-
-
62549148632
-
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
-
Jones RN, Moet GJ, Sader HS, et al. TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens. J Antimicrob Chemother 2009;63:716-20
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 716-720
-
-
Jones, R.N.1
Moet, G.J.2
Sader, H.S.3
-
32
-
-
57049089598
-
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains
-
Shaw KJ, Poppe S, Schaadt R, et al. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob Agents Chemother 2008;52:4442-7
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 4442-7
-
-
Shaw, K.J.1
Poppe, S.2
Schaadt, R.3
-
33
-
-
34247562698
-
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria
-
DOI 10.1016/j.molcel.2007.04.005, PII S1097276507002213
-
Leach KL, Swaney SM, Colca JR, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 2007;26:393-402 (Pubitemid 46687101)
-
(2007)
Molecular Cell
, vol.26
, Issue.3
, pp. 393-402
-
-
Leach, K.L.1
Swaney, S.M.2
Colca, J.R.3
McDonald, W.G.4
Blinn, J.R.5
Thomasco, LisaM.6
Gadwood, R.C.7
Shinabarger, D.8
Xiong, L.9
Mankin, A.S.10
-
34
-
-
84858244397
-
In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
-
Rodriguez-Avial I, Culebras E, Betriu C, et al. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J Antimicrob Chemother 2012;67:167-9
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 167-169
-
-
Rodriguez-Avial, I.1
Culebras, E.2
Betriu, C.3
-
35
-
-
71249138911
-
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700)
-
Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 2009;53:5265-74
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 5265-5274
-
-
Locke, J.B.1
Hilgers, M.2
Shaw, K.J.3
-
36
-
-
80051825841
-
Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins
-
Yamaki J, Synold T, Wong-Beringer A. Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins. Antimicrob Agents Chemother 2011;55:4432-5
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 4432-5
-
-
Yamaki, J.1
Synold, T.2
Wong-Beringer, A.3
-
37
-
-
78751689284
-
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections
-
Prokocimer P, Bien P, Surber J, et al. Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections. Antimicrob Agents Chemother 2011;55:583-92
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 583-592
-
-
Prokocimer, P.1
Bien, P.2
Surber, J.3
-
38
-
-
79959194196
-
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model
-
Louie A, Liu W, Kulawy R, Drusano GL. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model. Antimicrob Agents Chemother 2011;55:3453-60
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 3453-3460
-
-
Louie, A.1
Liu, W.2
Kulawy, R.3
Drusano, G.L.4
-
39
-
-
79952280648
-
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
-
Im WB, Choi SH, Park JY, et al. Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent. Eur J Med Chem 2011;46:1027-39
-
(2011)
Eur J Med Chem
, vol.46
, pp. 1027-1039
-
-
Im, W.B.1
Choi, S.H.2
Park, J.Y.3
-
43
-
-
73949088615
-
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): Studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines
-
Lemaire S, Van Bambeke F, Appelbaum PC, Tulkens PM. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. J Antimicrob Chemother 2009;64:1035-43
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 1035-1043
-
-
Lemaire, S.1
Van Bambeke, F.2
Appelbaum, P.C.3
Tulkens, P.M.4
-
47
-
-
33748192486
-
Linezolid for the treatment of patients with endocarditis: A systematic review of the published evidence
-
DOI 10.1093/jac/dkl219
-
Falagas ME, Manta KG, Ntziora F, Vardakas KZ. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006;58:273-80 (Pubitemid 44313381)
-
(2006)
Journal of Antimicrobial Chemotherapy
, vol.58
, Issue.2
, pp. 273-280
-
-
Falagas, M.E.1
Manta, K.G.2
Ntziora, F.3
Vardakas, K.Z.4
|